Send the following on WhatsApp
Continue to Chat基石藥業宣布普吉華(R)(普拉替尼膠囊)在中國獲批用於治療晚期或轉移性RET突變甲狀腺髓樣癌及RET融合陽性甲狀腺癌 https://geneonline.news/thyroid-cancer-tumor-immunotherapy/
基石藥業宣布普吉華(R)(普拉替尼膠囊)在中國獲批用於治療晚期或轉移性RET突變甲狀腺髓樣癌及RET融合陽性甲狀腺癌 https://geneonline.news/thyroid-cancer-tumor-immunotherapy/